Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Atherosclerosis. 2008 Jul 9;203(2):509–514. doi: 10.1016/j.atherosclerosis.2008.06.031

Table 1.

Clinical Characteristics of the Study Sample

Intermittent claudication
Ankle-brachial Index
Variable Mean (SD) or percent Yes or Vascular Intervention N=90 No N=2710 <0.9 N=111 0.9 to 1.0 N=225 >1.0 to 1.4 N=2464
Age, years 67 (9) 61 (9) 70 (8) 65 (10) 60 (9)
Women, % 43 54 50 71 52
Current smoking, % 27 13 30 26 12
Pack years among ever smokers, mean 63 (25) 43 (23) 65 (25) 47 (23) 41 (22)
Diabetes, % 29 12 26 20 11
Body mass index, kg/m2 29.7 (6.1) 28.0 (5.1) 28.2 (5.5) 28.5 (6.6) 28.0 (4.9)
Total/HDL cholesterol ratio 4.5 (1.4) 4.0 (1.3) 4.4 (1.5) 4.0 (1.5) 4.1 (1.3)
Lipid lowering treatment, % 49 19 40 28 19
Hypertension, % 74 44 76 62 42
Hypertension treatment, % 68 32 66 49 31
Aspirin use*, % 57 30 49 34 30
Prevalent cardiovascular disease, % 52 10 33 15 9
Hormone replacement among women, % 38 30 16 31 31
*

aspirin use is defined as 3 or more tablets per week

cardiovascular disease did not include intermittent claudication